0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erectile Dysfunction Oral Medications Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-37R12470
Home | Market Reports | Health| Reproductive Health
Global Erectile Dysfunction Oral Medications Market Research Report 2022
BUY CHAPTERS

Global Erectile Dysfunction Oral Medications Market Research Report 2025

Code: QYRE-Auto-37R12470
Report
February 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Erectile Dysfunction Oral Medications Market Size

The global market for Erectile Dysfunction Oral Medications was valued at US$ 139 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Erectile Dysfunction Oral Medications Market

Erectile Dysfunction Oral Medications Market

Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra) are oral medications that reverse erectile dysfunction by enhancing the effects of nitric oxide, a natural chemical your body produces that relaxes muscles in the penis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Oral Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Oral Medications.
The Erectile Dysfunction Oral Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erectile Dysfunction Oral Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Oral Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Erectile Dysfunction Oral Medications Market Report

Report Metric Details
Report Name Erectile Dysfunction Oral Medications Market
Accounted market size in year US$ 139 million
Forecasted market size in 2031 US$ 178 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Sildenafil
  • Tadalafil
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly, Pfizer, Bayer, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, BaiYunShan General Factory, Yabang Pharmacy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Erectile Dysfunction Oral Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Erectile Dysfunction Oral Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Erectile Dysfunction Oral Medications Market growing?

Ans: The Erectile Dysfunction Oral Medications Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Erectile Dysfunction Oral Medications Market size in 2031?

Ans: The Erectile Dysfunction Oral Medications Market size in 2031 will be US$ 178 million.

Who are the main players in the Erectile Dysfunction Oral Medications Market report?

Ans: The main players in the Erectile Dysfunction Oral Medications Market are Eli Lilly, Pfizer, Bayer, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, BaiYunShan General Factory, Yabang Pharmacy

What are the Application segmentation covered in the Erectile Dysfunction Oral Medications Market report?

Ans: The Applications covered in the Erectile Dysfunction Oral Medications Market report are Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce

What are the Type segmentation covered in the Erectile Dysfunction Oral Medications Market report?

Ans: The Types covered in the Erectile Dysfunction Oral Medications Market report are Sildenafil, Tadalafil, Others

Recommended Reports

Oral Medications

Men's Health Drugs

Cardiovascular Medicines

1 Erectile Dysfunction Oral Medications Market Overview
1.1 Product Definition
1.2 Erectile Dysfunction Oral Medications by Type
1.2.1 Global Erectile Dysfunction Oral Medications Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Oral Medications by Application
1.3.1 Global Erectile Dysfunction Oral Medications Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Global Erectile Dysfunction Oral Medications Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Oral Medications Revenue 2020-2031
1.4.2 Global Erectile Dysfunction Oral Medications Sales 2020-2031
1.4.3 Global Erectile Dysfunction Oral Medications Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Oral Medications Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Oral Medications Sales Market Share by Manufacturers (2020-2025)
2.2 Global Erectile Dysfunction Oral Medications Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Erectile Dysfunction Oral Medications Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Erectile Dysfunction Oral Medications, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Product Type & Application
2.7 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Date of Enter into This Industry
2.8 Global Erectile Dysfunction Oral Medications Market Competitive Situation and Trends
2.8.1 Global Erectile Dysfunction Oral Medications Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Erectile Dysfunction Oral Medications Players Market Share by Revenue
2.8.3 Global Erectile Dysfunction Oral Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Erectile Dysfunction Oral Medications Market Scenario by Region
3.1 Global Erectile Dysfunction Oral Medications Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Erectile Dysfunction Oral Medications Sales by Region: 2020-2031
3.2.1 Global Erectile Dysfunction Oral Medications Sales by Region: 2020-2025
3.2.2 Global Erectile Dysfunction Oral Medications Sales by Region: 2026-2031
3.3 Global Erectile Dysfunction Oral Medications Revenue by Region: 2020-2031
3.3.1 Global Erectile Dysfunction Oral Medications Revenue by Region: 2020-2025
3.3.2 Global Erectile Dysfunction Oral Medications Revenue by Region: 2026-2031
3.4 North America Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Oral Medications Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Erectile Dysfunction Oral Medications Sales by Country (2020-2031)
3.4.3 North America Erectile Dysfunction Oral Medications Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Oral Medications Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Erectile Dysfunction Oral Medications Sales by Country (2020-2031)
3.5.3 Europe Erectile Dysfunction Oral Medications Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Oral Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Erectile Dysfunction Oral Medications Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Erectile Dysfunction Oral Medications Sales by Region (2020-2031)
3.6.3 Asia Pacific Erectile Dysfunction Oral Medications Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Oral Medications Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Erectile Dysfunction Oral Medications Sales by Country (2020-2031)
3.7.3 Latin America Erectile Dysfunction Oral Medications Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Oral Medications Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Erectile Dysfunction Oral Medications Sales by Country (2020-2031)
3.8.3 Middle East and Africa Erectile Dysfunction Oral Medications Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Oral Medications Sales by Type (2020-2031)
4.1.1 Global Erectile Dysfunction Oral Medications Sales by Type (2020-2025)
4.1.2 Global Erectile Dysfunction Oral Medications Sales by Type (2026-2031)
4.1.3 Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2020-2031)
4.2 Global Erectile Dysfunction Oral Medications Revenue by Type (2020-2031)
4.2.1 Global Erectile Dysfunction Oral Medications Revenue by Type (2020-2025)
4.2.2 Global Erectile Dysfunction Oral Medications Revenue by Type (2026-2031)
4.2.3 Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2020-2031)
4.3 Global Erectile Dysfunction Oral Medications Price by Type (2020-2031)
5 Segment by Application
5.1 Global Erectile Dysfunction Oral Medications Sales by Application (2020-2031)
5.1.1 Global Erectile Dysfunction Oral Medications Sales by Application (2020-2025)
5.1.2 Global Erectile Dysfunction Oral Medications Sales by Application (2026-2031)
5.1.3 Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2020-2031)
5.2 Global Erectile Dysfunction Oral Medications Revenue by Application (2020-2031)
5.2.1 Global Erectile Dysfunction Oral Medications Revenue by Application (2020-2025)
5.2.2 Global Erectile Dysfunction Oral Medications Revenue by Application (2026-2031)
5.2.3 Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2020-2031)
5.3 Global Erectile Dysfunction Oral Medications Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly Erectile Dysfunction Oral Medications Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Erectile Dysfunction Oral Medications Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Erectile Dysfunction Oral Medications Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 S.K. Chemicals
6.4.1 S.K. Chemicals Company Information
6.4.2 S.K. Chemicals Description and Business Overview
6.4.3 S.K. Chemicals Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.4.4 S.K. Chemicals Erectile Dysfunction Oral Medications Product Portfolio
6.4.5 S.K. Chemicals Recent Developments/Updates
6.5 Teva Pharma
6.5.1 Teva Pharma Company Information
6.5.2 Teva Pharma Description and Business Overview
6.5.3 Teva Pharma Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharma Erectile Dysfunction Oral Medications Product Portfolio
6.5.5 Teva Pharma Recent Developments/Updates
6.6 Dong-A ST
6.6.1 Dong-A ST Company Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dong-A ST Erectile Dysfunction Oral Medications Product Portfolio
6.6.5 Dong-A ST Recent Developments/Updates
6.7 Petros Pharmaceuticals
6.7.1 Petros Pharmaceuticals Company Information
6.7.2 Petros Pharmaceuticals Description and Business Overview
6.7.3 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product Portfolio
6.7.5 Petros Pharmaceuticals Recent Developments/Updates
6.8 Seoul Pharma
6.8.1 Seoul Pharma Company Information
6.8.2 Seoul Pharma Description and Business Overview
6.8.3 Seoul Pharma Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Seoul Pharma Erectile Dysfunction Oral Medications Product Portfolio
6.8.5 Seoul Pharma Recent Developments/Updates
6.9 BaiYunShan General Factory
6.9.1 BaiYunShan General Factory Company Information
6.9.2 BaiYunShan General Factory Description and Business Overview
6.9.3 BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BaiYunShan General Factory Erectile Dysfunction Oral Medications Product Portfolio
6.9.5 BaiYunShan General Factory Recent Developments/Updates
6.10 Yabang Pharmacy
6.10.1 Yabang Pharmacy Company Information
6.10.2 Yabang Pharmacy Description and Business Overview
6.10.3 Yabang Pharmacy Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yabang Pharmacy Erectile Dysfunction Oral Medications Product Portfolio
6.10.5 Yabang Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Oral Medications Industry Chain Analysis
7.2 Erectile Dysfunction Oral Medications Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Oral Medications Production Mode & Process Analysis
7.4 Erectile Dysfunction Oral Medications Sales and Marketing
7.4.1 Erectile Dysfunction Oral Medications Sales Channels
7.4.2 Erectile Dysfunction Oral Medications Distributors
7.5 Erectile Dysfunction Oral Medications Customer Analysis
8 Erectile Dysfunction Oral Medications Market Dynamics
8.1 Erectile Dysfunction Oral Medications Industry Trends
8.2 Erectile Dysfunction Oral Medications Market Drivers
8.3 Erectile Dysfunction Oral Medications Market Challenges
8.4 Erectile Dysfunction Oral Medications Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Erectile Dysfunction Oral Medications Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Erectile Dysfunction Oral Medications Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Erectile Dysfunction Oral Medications Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Erectile Dysfunction Oral Medications Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Erectile Dysfunction Oral Medications Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Erectile Dysfunction Oral Medications Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Erectile Dysfunction Oral Medications Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Erectile Dysfunction Oral Medications, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Erectile Dysfunction Oral Medications, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Erectile Dysfunction Oral Medications, Product Type & Application
 Table 12. Global Key Manufacturers of Erectile Dysfunction Oral Medications, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Erectile Dysfunction Oral Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Oral Medications as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Erectile Dysfunction Oral Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Erectile Dysfunction Oral Medications Sales by Region (2020-2025) & (K Units)
 Table 18. Global Erectile Dysfunction Oral Medications Sales Market Share by Region (2020-2025)
 Table 19. Global Erectile Dysfunction Oral Medications Sales by Region (2026-2031) & (K Units)
 Table 20. Global Erectile Dysfunction Oral Medications Sales Market Share by Region (2026-2031)
 Table 21. Global Erectile Dysfunction Oral Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Erectile Dysfunction Oral Medications Revenue Market Share by Region (2020-2025)
 Table 23. Global Erectile Dysfunction Oral Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Erectile Dysfunction Oral Medications Revenue Market Share by Region (2026-2031)
 Table 25. North America Erectile Dysfunction Oral Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Erectile Dysfunction Oral Medications Sales by Country (2020-2025) & (K Units)
 Table 27. North America Erectile Dysfunction Oral Medications Sales by Country (2026-2031) & (K Units)
 Table 28. North America Erectile Dysfunction Oral Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Erectile Dysfunction Oral Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Erectile Dysfunction Oral Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Erectile Dysfunction Oral Medications Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Erectile Dysfunction Oral Medications Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Erectile Dysfunction Oral Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Erectile Dysfunction Oral Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Erectile Dysfunction Oral Medications Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Erectile Dysfunction Oral Medications Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Erectile Dysfunction Oral Medications Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Erectile Dysfunction Oral Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Erectile Dysfunction Oral Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Erectile Dysfunction Oral Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Erectile Dysfunction Oral Medications Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Erectile Dysfunction Oral Medications Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Erectile Dysfunction Oral Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Erectile Dysfunction Oral Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Erectile Dysfunction Oral Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Erectile Dysfunction Oral Medications Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Erectile Dysfunction Oral Medications Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Erectile Dysfunction Oral Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Erectile Dysfunction Oral Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Erectile Dysfunction Oral Medications Sales (K Units) by Type (2020-2025)
 Table 51. Global Erectile Dysfunction Oral Medications Sales (K Units) by Type (2026-2031)
 Table 52. Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2020-2025)
 Table 53. Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2026-2031)
 Table 54. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2020-2025)
 Table 57. Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2026-2031)
 Table 58. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Erectile Dysfunction Oral Medications Sales (K Units) by Application (2020-2025)
 Table 61. Global Erectile Dysfunction Oral Medications Sales (K Units) by Application (2026-2031)
 Table 62. Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2020-2025)
 Table 63. Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2026-2031)
 Table 64. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Erectile Dysfunction Oral Medications Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2020-2025)
 Table 67. Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2026-2031)
 Table 68. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Application (2026-2031)
 Table 70. Eli Lilly Company Information
 Table 71. Eli Lilly Description and Business Overview
 Table 72. Eli Lilly Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Eli Lilly Erectile Dysfunction Oral Medications Product
 Table 74. Eli Lilly Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Erectile Dysfunction Oral Medications Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bayer Erectile Dysfunction Oral Medications Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. S.K. Chemicals Company Information
 Table 86. S.K. Chemicals Description and Business Overview
 Table 87. S.K. Chemicals Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. S.K. Chemicals Erectile Dysfunction Oral Medications Product
 Table 89. S.K. Chemicals Recent Developments/Updates
 Table 90. Teva Pharma Company Information
 Table 91. Teva Pharma Description and Business Overview
 Table 92. Teva Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Pharma Erectile Dysfunction Oral Medications Product
 Table 94. Teva Pharma Recent Developments/Updates
 Table 95. Dong-A ST Company Information
 Table 96. Dong-A ST Description and Business Overview
 Table 97. Dong-A ST Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Dong-A ST Erectile Dysfunction Oral Medications Product
 Table 99. Dong-A ST Recent Developments/Updates
 Table 100. Petros Pharmaceuticals Company Information
 Table 101. Petros Pharmaceuticals Description and Business Overview
 Table 102. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product
 Table 104. Petros Pharmaceuticals Recent Developments/Updates
 Table 105. Seoul Pharma Company Information
 Table 106. Seoul Pharma Description and Business Overview
 Table 107. Seoul Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Seoul Pharma Erectile Dysfunction Oral Medications Product
 Table 109. Seoul Pharma Recent Developments/Updates
 Table 110. BaiYunShan General Factory Company Information
 Table 111. BaiYunShan General Factory Description and Business Overview
 Table 112. BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. BaiYunShan General Factory Erectile Dysfunction Oral Medications Product
 Table 114. BaiYunShan General Factory Recent Developments/Updates
 Table 115. Yabang Pharmacy Company Information
 Table 116. Yabang Pharmacy Description and Business Overview
 Table 117. Yabang Pharmacy Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Yabang Pharmacy Erectile Dysfunction Oral Medications Product
 Table 119. Yabang Pharmacy Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Erectile Dysfunction Oral Medications Distributors List
 Table 123. Erectile Dysfunction Oral Medications Customers List
 Table 124. Erectile Dysfunction Oral Medications Market Trends
 Table 125. Erectile Dysfunction Oral Medications Market Drivers
 Table 126. Erectile Dysfunction Oral Medications Market Challenges
 Table 127. Erectile Dysfunction Oral Medications Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Erectile Dysfunction Oral Medications
 Figure 2. Global Erectile Dysfunction Oral Medications Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Erectile Dysfunction Oral Medications Market Share by Type: 2024 & 2031
 Figure 4. Sildenafil Product Picture
 Figure 5. Tadalafil Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Erectile Dysfunction Oral Medications Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Erectile Dysfunction Oral Medications Market Share by Application: 2024 & 2031
 Figure 9. Hospital Pharmacies
 Figure 10. Private Clinics
 Figure 11. Retail Pharmacies
 Figure 12. E-Commerce
 Figure 13. Global Erectile Dysfunction Oral Medications Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Erectile Dysfunction Oral Medications Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Erectile Dysfunction Oral Medications Sales (2020-2031) & (K Units)
 Figure 16. Global Erectile Dysfunction Oral Medications Average Price (US$/Unit) & (2020-2031)
 Figure 17. Erectile Dysfunction Oral Medications Report Years Considered
 Figure 18. Erectile Dysfunction Oral Medications Sales Share by Manufacturers in 2024
 Figure 19. Global Erectile Dysfunction Oral Medications Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Erectile Dysfunction Oral Medications Players: Market Share by Revenue in Erectile Dysfunction Oral Medications in 2024
 Figure 21. Erectile Dysfunction Oral Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Erectile Dysfunction Oral Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Erectile Dysfunction Oral Medications Sales Market Share by Country (2020-2031)
 Figure 24. North America Erectile Dysfunction Oral Medications Revenue Market Share by Country (2020-2031)
 Figure 25. United States Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Erectile Dysfunction Oral Medications Sales Market Share by Country (2020-2031)
 Figure 28. Europe Erectile Dysfunction Oral Medications Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Erectile Dysfunction Oral Medications Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Erectile Dysfunction Oral Medications Revenue Market Share by Region (2020-2031)
 Figure 36. China Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Erectile Dysfunction Oral Medications Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Erectile Dysfunction Oral Medications Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Erectile Dysfunction Oral Medications Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Erectile Dysfunction Oral Medications Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Erectile Dysfunction Oral Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Erectile Dysfunction Oral Medications by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Erectile Dysfunction Oral Medications by Type (2020-2031)
 Figure 55. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Erectile Dysfunction Oral Medications by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Erectile Dysfunction Oral Medications by Application (2020-2031)
 Figure 58. Global Erectile Dysfunction Oral Medications Price (US$/Unit) by Application (2020-2031)
 Figure 59. Erectile Dysfunction Oral Medications Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String